{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Tonawanda",
      "address_1": "100 Colvin Woods Pkwy",
      "reason_for_recall": "Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.",
      "address_2": "Ste 300",
      "product_quantity": "136 units",
      "code_info": "Lot#: 18098@1, Exp. 7/16/2018",
      "center_classification_date": "20180326",
      "distribution_pattern": "NY only",
      "state": "NY",
      "product_description": "Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL  Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01",
      "report_date": "20180328",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Pine Pharmaceuticals, LLC",
      "recall_number": "D-0607-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "79457",
      "termination_date": "20180423",
      "recall_initiation_date": "20180305",
      "postal_code": "14150-6974",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}